Stereotaxis (STXS) Research & Development (2010 - 2026)

Stereotaxis (STXS) has 17 years of Research & Development data on file, last reported at $2.4 million in Q1 2026.

• Research & Development for Q1 2026 came in at $2.4 million, up 2.0% year-over-year; the trailing twelve-month figure through Mar 2026 was $9.4 million (down 4.43% YoY), and the FY2025 annual result was $9.4 million, down 3.86% from the prior year.
• Research & Development slipped to $2.4 million in Q1 2026 per STXS's latest filing, from $2.7 million in the prior quarter.
• Over five years, Research & Development peaked at $2.9 million in Q2 2022 and troughed at $1.8 million in Q2 2025.
• A 5-year average of $2.5 million and a median of $2.5 million in 2024 frame the typical range for Research & Development.
• The sharpest annual moves came in 2024 and 2025: Research & Development increased 26.13% in 2024, then slipped 21.82% in 2025.
• A 5-year view of Research & Development shows it stood at $2.4 million in 2022, then declined by 7.83% to $2.2 million in 2023, then increased by 26.13% to $2.8 million in 2024, then slipped by 2.87% to $2.7 million in 2025, then retreated by 11.55% to $2.4 million in 2026.
• Business Quant data shows STXS's Research & Development at $2.4 million in Q1 2026, $2.7 million in Q4 2025, and $2.5 million in Q3 2025.